Skip to main content
Nevada Public Radio
  • News 88.9 KNPR
  • Classical 89.7 kcnv
  • Magazine Desert Companion
  • About

    How to reach us

    1289 S. Torrey Pines Dr.
    Las Vegas, NV 89146

    Main Number:  1-702-258-9895
    Toll Free: 1-888-258-9895

    More contact info

     

     

      • Staff
      • Board of Directors
      • Employment
      • CPB Compliance
      • Our Policies
      • Listen on the Radio
      • Other Ways to Listen
      • Sign-up for NVPR News
      • FCC Public Inspection File
      • CPB Funding
      • History
    • News 88.9 KNPR
    • Classical 89.7 KCNV
    • Desert Companion
  • Programs

    On News 88.9 KNPR

    On Classical 89.7

    News

    • All Things Considered
    • BBC World Service
    • Here & Now
    • Hidden Brain
    • It's Been a Minute with Sam Sanders
    • KNPR's State of Nevada
    • Marketplace
    • Morning Edition
    • On Point
    • On the Media
    • Planet Money - How I Built This
    • Reveal
    • The Daily
    • The Takeaway
    • Weekend Edition Saturday
    • Weekend Edition Sunday

    Humor

    • Ask Me Another
    • Live Wire!
    • Wait Wait...Don't Tell Me!

    Arts & Life

    • Bullseye
    • Desert Bloom
    • Fresh Air
    • Nevada Yesterdays
    • Radiolab
    • Snap Judgment
    • Sound Opinions
    • TED Radio Hour
    • The Business
    • The Moth
    • This American Life

    Classical

    • Chicago Symphony Orchestra
    • Classical Music
    • Concierto
    • From the Top
    • Music from the Hearts of Space
    • New York Philharmonic
    • Performance Today
    • Pipedreams
    • Pittsburgh Symphony Orchestra
    • Sunday Baroque
    • SymphonyCast

    Special Projects

    • Race and Racism in Nevada
    • StoryCorps Virtual: Las Vegas
    • Coronavirus - What You Need to Know
    • Fifth Street
  • Projects
  • Support
      • Support NVPR
      • Contact Member Services
      • Corporate Support
      • Donate your Car
      • Give Voice Major Gift Initiative
      • myPublicRadio
  • myPublicRadio
  • Donate Now
      • Member Benefits
      • Planned Giving
      • Volunteer

Main menu

Search

Listen

News 88.9 KNPR
Classical 89.7 KCNV
Podcasts view all

member station

Support
Subscribe to pfizer

pfizer

NPR
Goats and Soda
A scientist works on COVID-19 samples to find variations of the virus at the Croix-Rousse Hospital laboratory in Lyon, France, in January.
Tweet Share on Facebook Share on Google+ Email

Can Vaccines Stop Variants? Here's What We Know So Far

Apr 09, 2021
One of the hottest areas of research right now: studies to determine how well current vaccines work against emerging coronavirus "variants of concern."
  • Listen Download
NPR
Shots - Health News
President Biden inspects COVID-19 vaccine freezers at a Pfizer plant in Kalamazoo, Mich., with White House Coronavirus Response Coordinator Jeffrey Zients, Michigan Gov. Gretchen Whitmer and Pfizer CEO Albert Bourla on Feb. 19.
Tweet Share on Facebook Share on Google+ Email

Moderna And Pfizer On Track To Hit Vaccine Production Goals

Mar 11, 2021
Pfizer and Moderna each agreed to supply 100 million doses of COVID-19 vaccine to the U.S. by the end of March. With just under three weeks left, both companies have their work cut out for them.
  • Listen Download
NPR
Goats and Soda
An employee makes dry ice pellets at Capitol Carbonic, a dry ice factory in Baltimore in Nov. 2020. Dry ice helps keep COVID-19 vaccines cool during transport.
Tweet Share on Facebook Share on Google+ Email

What Is A Cold Chain? And Why Do So Many Vaccines Need It?

Feb 24, 2021
Many of the coronavirus vaccines like it cold. Really cold. Sub-zero cold. Why is this the case? And how is the world handling this frigid requirement?
NPR
The Coronavirus Crisis
Israelis receive a Pfizer-BioNTech COVID-19 vaccine from medical professionals at a vaccination center set up on a mall parking lot in Givataim, Israel, during a nationwide lockdown to curb the spread of the virus, on Jan. 20.
Tweet Share on Facebook Share on Google+ Email

Vaccines For Data: Israel's Pfizer Deal Drives Quick Rollout — And Privacy Worries

Jan 31, 2021
Israel paid a premium, locked in an early supply of Pfizer-BioNTech vaccines and agreed to share data from Israel's centralized trove of medical statistics. Privacy advocates have some misgivings.
  • Listen Download
NPR
Shots - Health News
A COVID-19 vaccine hub taking appointments only stands in Brooklyn as New York City begins to run low on doses Friday.
Tweet Share on Facebook Share on Google+ Email

Moderna And Pfizer Need To Nearly Double COVID-19 Vaccine Deliveries To Meet Goals

Jan 22, 2021
The two companies making COVID-19 vaccines each promised to deliver 100 million doses to the federal government by the end of March. So far, they appear to be running behind.
  • Listen Download
NPR
Coronavirus Updates
The U.S. government has reached a deal with Pfizer to purchase 100 million more doses of the vaccine developed jointly with BioNTech.
Tweet Share on Facebook Share on Google+ Email

U.S. Reaches Deal With Pfizer For 100 Million More Vaccine Doses

Dec 23, 2020

The new deal effectively doubles the federal government's order from the company. Pfizer says the U.S. government has agreed to pay $1.95 billion for the additional doses.

NPR
Coronavirus Updates
U.S. Army General Gustave Perna told reporters Saturday that some 7.9 million doses of COVID-19 vaccines are ready for distribution next week.
Tweet Share on Facebook Share on Google+ Email

Warp Speed Official: 7.9 Million Doses Of Vaccine Ready For Distribution Next Week

Dec 19, 2020
The top military official with the federal vaccine effort spoke less than 24 hours after Moderna's COVID-19 vaccine became the second to receive an emergency use authorization from the FDA.
NPR
Coronavirus Updates
An example of a vial that will carry the COVID-19 vaccine produced by Pfizer and BioNTech sits on display during a Senate subcommittee hearing Thursday.
Tweet Share on Facebook Share on Google+ Email

FDA Authorizes COVID-19 Vaccine For Emergency Use In U.S.

Dec 11, 2020
Pfizer and BioNTech's vaccine is the first to receive an emergency authorization from the Food and Drug Administration. Officials say it may be ready for widespread inoculations within days.
NPR
National
Food and Drug Administration building is shown Thursday, in Silver Spring, Md. A U.S. government advisory panel convened to decide whether to endorse emergency use of Pfizer's COVID-19 vaccine to help conquer the outbreak that has killed close to 300,000
Tweet Share on Facebook Share on Google+ Email

Transporting And Distributing Vaccines Will Be 'Unprecedented' Logistical Operation

Dec 11, 2020
As FDA emergency use authorization of Pfizer and Moderna vaccines nears, airlines, FedEx and UPS prepare to transport millions of vials of life saving shots.
  • Listen Download
NPR
National
Dry ice will be used to help keep the Pfizer vaccine at ultracold temperatures.
Tweet Share on Facebook Share on Google+ Email

At Hospitals, A Race To Save 'Hundreds Of Thousands' Of Lives With New Vaccine

Dec 09, 2020
With the first COVID-19 vaccine doses expected to be shipped out within days, health care providers are scrambling to prepare for an unprecedentedly high-stakes vaccine rollout.
  • Listen Download
NPR
Coronavirus Updates
A nurse in the U.K. prepares to administer COVID-19 vaccinations this week. Canadian health officials on Wednesday authorized the use of the Pfizer-BioNTech vaccine.
Tweet Share on Facebook Share on Google+ Email

Canada Authorizes Use Of Pfizer COVID-19 Vaccine

Dec 09, 2020
The vaccine produced by Pfizer and BioNTech is the first to be authorized by Canadian health officials. The decision makes Canada just the third country in the world to grant such an authorization.
KNPR
KNPR's State of Nevada
Tweet Share on Facebook Share on Google+ Email

Immunologist On COVID-19 Vaccine Technology

Dec 08, 2020

A vaccine for COVID-19 is on everyone’s minds right now. It’s seen as a possible light at the end of what has been a dark tunnel of a year.  

  • Listen Download
NPR
The Coronavirus Crisis
A woman wears a mask as she walks by Pfizer's world headquarters in New York last month.
Tweet Share on Facebook Share on Google+ Email

EU Could Approve Pfizer, BioNTech COVID-19 Vaccine In December

Dec 01, 2020
If approved, the vaccine could be distributed before the end of the year, BioNTech says.
NPR
Medical Treatments
The pharmaceutical giant Pfizer is formally requesting federal approval for emergency use of the company's COVID-19 vaccine
Tweet Share on Facebook Share on Google+ Email

Pfizer Asks FDA To Approve Its COVID-19 Vaccine For Emergency Use

Nov 20, 2020

The pharmaceutical giant and partner BioNTech announced Friday that they are submitting a formal request to the Food and Drug Administration, just days after the vaccine was shown to be 95% effective.

NPR
Coronavirus Updates
Pfizer CEO Albert Bourla says he expects the company will produce enough of its COVID-19 vaccine to reach 25 million people by the end of the year.
Tweet Share on Facebook Share on Google+ Email

Pfizer CEO On Next Steps For Coronavirus Vaccine And His Controversial Stock Trade

Nov 20, 2020
Albert Bourla, head of the pharmaceutical giant, discusses plans for distributing its vaccine, which it says is 95% effective, and explains the timing of his $5.6 mllion sale of Pfizer stock.
  • Listen Download
NPR
Shots - Health News
Pfizer plans to file within days with the Food and Drug Administration to allow emergency use of its COVID-19 vaccine.
Tweet Share on Facebook Share on Google+ Email

Pfizer To Seek FDA OK For COVID-19 Vaccine 'Within Days'

Nov 18, 2020
The vaccine was found to be 95% effective in an updated study analysis. Safety data required by the Food and Drug Administration showed no serious concerns, the company said.
  • Listen Download
NPR
Shots - Health News
The Pfizer COVID-19 vaccine needs to be stored at minus 70 Celsius. Health care providers will need to store it either in dry ice for shorter stints or in specialized freezers.
Tweet Share on Facebook Share on Google+ Email

Why Does Pfizer's COVID-19 Vaccine Need To Be Kept Colder Than Antarctica?

Nov 17, 2020
One of the two leading vaccine candidates requires deep, deep freezing. Here's how communities are working to solve for this and how the new Moderna vaccine could help.
  • Listen Download
NPR
Investigations
Albert Bourla, chairman and CEO of Pfizer, sold millions of dollars' worth of company stock on Monday as part of a preset plan. But NPR found irregularities about when the CEO entered into that plan.
Tweet Share on Facebook Share on Google+ Email

Pfizer CEO Sold Millions In Stock After Coronavirus Vaccine News, Raising Questions

Nov 11, 2020
Pfizer's CEO sold $5.6 million worth of stock on Monday. The company says the stock sale was made as part of a preset plan. But NPR found irregularities about when the CEO entered into that plan.
  • Listen Download
NPR
Coronavirus Live Updates
The first patient enrolled in Pfizer's COVID-19 vaccine clinical trial at the University of Maryland School of Medicine in Baltimore receives an injection in May.
Tweet Share on Facebook Share on Google+ Email

Pfizer COVID-19 Vaccine Won't Be Ready By Election Day

Oct 16, 2020
Pfizer Chairman and CEO Albert Bourla said in a public statement Friday that the company won't have data showing that the vaccine is safe before the third week of November at the earliest.
NPR
Coronavirus Live Updates
The agreement also would allow the federal government to acquire an additional 500 million doses of the Pfizer vaccine.
Tweet Share on Facebook Share on Google+ Email

U.S. To Get 100 Million Doses of Pfizer Coronavirus Vaccine In $1.95 Billion Deal

Jul 22, 2020
If the company's vaccine candidate pans out, Americans can receive it for free under the deal. The arrangement is part of the U.S. government's push to have a vaccine widely available by January.
NPR
The Two-Way
Pfizer said it would be abandoning its neuroscience development programs and allocating its spending elsewhere.
Tweet Share on Facebook Share on Google+ Email

Pfizer Halts Research Into Alzheimer's And Parkinson's Treatments

Jan 08, 2018
The pharmaceutical giant said it would be abandoning its neuroscience development programs and allocating its spending elsewhere. The move also means the company will lay off some 300 employees.
KNPR
Newscast headlines

Nevada Won’t Return Execution Drug To Pfizer

Nov 20, 2017

 

LINCOLN, Neb.

Tweet Share on Facebook Share on Google+ Email
NPR
The Two-Way
This combination of undated photos provided by the Arkansas Department of Correction shows the death row inmates in question. Top row (from left): Jack Harold Jones Jr., Marcel Williams, Stacey E. Johnson, Ledell Lee. Bottom row (from left): Jason F. McG
Tweet Share on Facebook Share on Google+ Email

Courts Block 7 Executions Set For 11-Day Span In Arkansas

Apr 14, 2017
A county judge and the state supreme court ordered the state not to put the inmates to death. The larger case challenges lethal drugs. The other argues that the inmate is not sane.
NPR
Shots - Health News
Syphilis can be wiped out with one to three shots of penicillin.
Tweet Share on Facebook Share on Google+ Email

Penicillin Shortage Could Be A Problem For People With Syphilis

May 23, 2016
The medication is the only one available to prevent an infected pregnant woman from passing the disease to a fetus. Pfizer says the shortage should be over in July.
  • Listen Download
NPR
The Two-Way
Pfizer's corporate headquarters in midtown Manhattan.
Tweet Share on Facebook Share on Google+ Email

Pfizer To Stop Selling Drugs For Use In Lethal Injections

May 13, 2016
The drugmaker was the "last remaining open-market source of drugs used in executions," The New York Times reported. Other U.S. and European firms had already blocked drugs from use in executions.

Pages

  • 1
  • 2
  • next ›
  • last »
  • home
  • How to reach us
  • About
  • Support
  • Twitter
  • Facebook
  • NVPR News
  • Instagram

© All Rights Reserved. | Privacy Policy

PRXNPRAPMBBC INN